DUPONT CAPITAL MANAGEMENT CORP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$24,754
-84.8%
5,730
-73.6%
0.00%
-90.0%
Q3 2022$163,000
+83.1%
21,702
+145.4%
0.01%
+150.0%
Q2 2022$89,000
-19.1%
8,8450.0%0.00%0.0%
Q1 2022$110,000
-44.2%
8,845
+2.7%
0.00%
-42.9%
Q4 2021$197,000
-33.4%
8,612
-35.7%
0.01%
-22.2%
Q3 2021$296,00013,3970.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders